Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
To alleviate the gastrointestinal reaction of patients, at the beginning of the application of these drugs, clinical workers should know that the dosage should be gradually increased from a small dosage to enhance patients tolerance
A one-time gene therapy, Roctavian contains a healthy gene for factor VIII
Clinical trial data suggest that gastrointestinal adverse effects typically peak during dose escalation and diminish with continued therapy at stable doses
Thus, although an important point to keep attention to, data so far does not indicate that cardiovascular complications are a major cause for concern at the moment (gastrointestinal problems being by far the larger problem experienced by people on GLP1R agonists )
US$ 20.29
US$ 24.61
US$ 28.50
